Biotech · Private company
PRG Science & Technology Co., Ltd.
Track this companyFree. Adds PRG Science & Technology Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- LonafarnibPhase 2 · Hutchinson-Gilford Progeria SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ProgerininPhase 2 · Hutchinson-Gilford Progeria SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ProgerininPhase 2 · Werner SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- AmisodinPhase 1 · Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner SyndromePHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT05847179 · fetched Nov 12, 2026
- Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral SclerosisPHASE1 · RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT07221240 · fetched Nov 12, 2026
- Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)PHASE2 · COMPLETED · started Jan 13, 2025ClinicalTrials.gov NCT06775041 · fetched Nov 12, 2026
- Phase I Study of Progerinin in Healthy VolunteersPHASE1 · COMPLETED · started Aug 24, 2020ClinicalTrials.gov NCT04512963 · fetched Nov 12, 2026